GlassScriptPhysician profile
Ranganathan Govindaraj
NPI 1871653683
$2,953.43
in general payments reported to CMS, 2019-2025
19 companies · $603 in 2025
The $603 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.17 · 2020: $12.54 · 2021: $1,249 · 2022: $279 · 2023: $400 · 2024: $345 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898 · Honoraria: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.85 |
| Honoraria | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $954.34 | 2019-2021 | |
| Becton, Dickinson and Company | $450.00 | 2025 | |
| Mml US, INC. | $269.61 | 2024-2025 | Reactiv8 |
| Nalu Medical, INC. | $231.91 | 2021-2022 | |
| Medtronic, INC. | $147.53 | 2023 | Osteocool Rf Ablation System, Intellis Adaptivestim |
| Si-Bone, INC. | $125.19 | 2021 | |
| Averitas Pharma INC. | $121.83 | 2023 | Qutenza |
| Spr Therapeutics, INC | $119.88 | 2023-2024 | Sprint Pns System |
| Abbott Laboratories | $116.41 | 2024 | Proclaim |
| Grt US Holding, INC. | $99.70 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $94.31 | 2021 | |
| Fresenius Kabi USA, LLC | $84.90 | 2023 | Ivenix Infusion System |
| Stimwave Technologies Incorporated | $35.28 | 2019 | |
| Masimo Corporation | $26.50 | 2022 | |
| Fisher & Paykel Healthcare INC | $22.75 | 2025 | Fisher & Paykel Healthcare |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.42 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.94 | 2024 | Xarelto |
| Pfizer INC. | $14.50 | 2019 | |
| Epimed International, INC | $5.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranganathan Govindaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.